Data / Form D filings / Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc.: Form D filings
Enveda Therapeutics, Inc., a biotechnology company in Boulder, CO, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on March 7, 2023, reports $62.5 million sold of a $62.5 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1880 S Flatiron Ct. Ste. K, Boulder, CO, 80301
- Phone
- (415) 323-5252
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1821392
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | New notice | $62,459,761 | $62,459,761 | 26 | Aug 25, 2022 | sec.gov | |
| Aug 24, 2020 | New notice | $4,999,998 | $4,999,998 | 10 | Aug 11, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rohit Sharma | Director | |
| Zavain Dar | Director | |
| Bruce Beutel | Director | |
| Daniel Wee | Executive Officer | |
| Shaquille Vayda | Director | |
| Viswa Colluru | Executive Officer, Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Mar 6, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Enveda Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.